ICAM1 and myocardial infarction: Increasing the surface adhesion of MSCs, which can be specifically targeted to overexpressed ICAM1 in response to local inflammation, significantly enhances the adhesion of MSCs to the infarcted heart and enhances the treatment of MI [36].